Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients

• Published in: Endocrine 2024-06, Vol.84 (3), p.1081-1087
• Main Authors: Garcia Alves-Junior, Paulo Alonso, de Andrade Barreto, Marise Codeço, de Andrade, Fernanda Accioly, Bulzico, Daniel Alves, Corbo, Rossana, Vaisman, Fernanda
• Format: Article
• Language: English
• Subjects: Adolescent; Child; Child, Preschool; Diabetes; Endocrinology; Female; Humanities and Social Sciences; Humans; Internal Medicine; Iodine; Iodine Radioisotopes - therapeutic use; Male; Medicine; Medicine & Public Health; Metastases; Metastasis; multidisciplinary; Neoplasm Metastasis; Original Article; Patients; Pediatrics; Retrospective Studies; Risk groups; Science; Sensitivity analysis; Thyroglobulin; Thyroglobulin - blood; Thyroid cancer; Thyroid carcinoma; Thyroid Neoplasms - blood; Thyroid Neoplasms - diagnostic imaging; Thyroid Neoplasms - pathology; Thyroidectomy; Treatment Outcome; Whole Body Imaging
• ISSN: 1559-0100; 1355-008X; 1559-0100
• DOI: 10.1007/s12020-024-03691-w

Introduction Differentiated thyroid carcinoma (DTC) is a rare oncological disease in the pediatric population, presenting with a more aggressive form. Stimulated thyroglobulin (sTg) and the 131-iodine whole-body scans (WBSs) are known adult markers related to the presence of distant metastasis. Little is known about their roles in the pediatric population. Purpose To evaluate sTg levels and diagnostic WBS (DxWBS) as predictors of distant metastasis after thyroidectomy and to correlate with the response to treatment at the end of follow-up in pediatric DTC. Materials and methods Patients under 19 years old diagnosed with DTC from 1980 to 2022 were retrospectively evaluated. sTg values and WBS were assessed after thyroidectomy and prior radioiodine treatment (RIT) and correlated with the possibility of finding distant metastasis and response to treatment at the end of follow-up. Results In a total of 142 patients with a median age of 14.6 (4–18) years who were followed for 9.5 ± 7.2 years and classified according to the ATA risk of recurrence as low (28%), intermediate (16%), and high risk (56%), 127 patients had their sTg evaluated. A sTg value of 21.7 ng/dl yielded a sensitivity of 88% compared to 30% for DxWBS in predicting distant metastasis. Specificity was 60% and 100% respectively. 42% of patients obtained discordant results between DxWBS and RxWBS. In high-risk patients, sTg levels were particularly able to differentiate those who would have distant metastasis with better diagnostic accuracy than the WBSs. Conclusions The sTg level had better performance in detecting distant metastases in pediatric DTC than the DxWBS. DxWBS’s low performance suggests that caution should be taken in interpreting their findings in terms of the underdiagnosis for metastatic disease, especially when the sTg level already suggests distant disease.